| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 03:53:09 UTC |
|---|
| Updated at | 2022-04-28 03:53:09 UTC |
|---|
| NP-MRD ID | NP0058534 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Fraxinellone |
|---|
| Description | Fraxinellone belongs to the class of organic compounds known as isobenzofurans. These are organic aromatic compounds containing an isobenzofuran moiety. Fraxinellone is found in Dictamnus albus L. , Dictamnus angustifolius, Dictamnus dasycarpus , Dictamnus radicis Cortex, Dictamus albus , Fagaropsis glabra, Melia azedarach and Raulinoa echinata. Fraxinellone was first documented in 2021 (PMID: 34717966). Based on a literature review a small amount of articles have been published on Fraxinellone (PMID: 34519225) (PMID: 34463097) (PMID: 33953684) (PMID: 33845055). |
|---|
| Structure | CC1=C2C(=O)O[C@@H](C3=COC=C3)[C@]2(C)CCC1 InChI=1S/C14H16O3/c1-9-4-3-6-14(2)11(9)13(15)17-12(14)10-5-7-16-8-10/h5,7-8,12H,3-4,6H2,1-2H3/t12-,14+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C14H16O3 |
|---|
| Average Mass | 232.2790 Da |
|---|
| Monoisotopic Mass | 232.10994 Da |
|---|
| IUPAC Name | (3R,3aR)-3-(furan-3-yl)-3a,7-dimethyl-1,3,3a,4,5,6-hexahydro-2-benzofuran-1-one |
|---|
| Traditional Name | fraxinellone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C2C(=O)O[C@@H](C3=COC=C3)[C@]2(C)CCC1 |
|---|
| InChI Identifier | InChI=1S/C14H16O3/c1-9-4-3-6-14(2)11(9)13(15)17-12(14)10-5-7-16-8-10/h5,7-8,12H,3-4,6H2,1-2H3/t12-,14+/m0/s1 |
|---|
| InChI Key | XYYAFLHHHZVPRN-GXTWGEPZSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as isobenzofurans. These are organic aromatic compounds containing an isobenzofuran moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isobenzofurans |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Isobenzofurans |
|---|
| Alternative Parents | |
|---|
| Substituents | - Isobenzofuran
- Gamma butyrolactone
- Furan
- Tetrahydrofuran
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Heteroaromatic compound
- Lactone
- Carboxylic acid ester
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Oxacycle
- Carbonyl group
- Organooxygen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Lu T, Peng S, Wang J, Yang S, Xu X, Li H, Shen H, Li X, Cui G, Chen G: Fraxinellone ameliorates intracerebral hemorrhage-induced secondary brain injury by regulating Kruppel-like transcription factor 2 expression in rats. Brain Res Bull. 2021 Dec;177:340-351. doi: 10.1016/j.brainresbull.2021.10.018. Epub 2021 Oct 28. [PubMed:34717966 ]
- Li J, Feng T, Yang W, Xu Y, Wang S, Cai H, Liu Z, Qiang H, Zhang J: Rational formulation engineering of fraxinellone utilizing 6-O-alpha-D-maltosyl-beta-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy. Drug Deliv. 2021 Dec;28(1):1890-1902. doi: 10.1080/10717544.2021.1976310. [PubMed:34519225 ]
- Bui D, Yin T, Duan S, Wei B, Yang P, Wong SJ, You M, Singh R, Hu M: Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer. J Nat Prod. 2021 Sep 24;84(9):2486-2495. doi: 10.1021/acs.jnatprod.1c00501. Epub 2021 Aug 31. [PubMed:34463097 ]
- He B, Zhang W, He J: Fraxinellone Has Anticancer Activity by Inducing Osteosarcoma Cell Apoptosis via Promoting Excessive Autophagy Flux. Front Pharmacol. 2021 Apr 19;12:653212. doi: 10.3389/fphar.2021.653212. eCollection 2021. [PubMed:33953684 ]
- Zheng B, Yuan M, Wang S, Tan Y, Xu Y, Ye J, Gao Y, Sun X, Wang T, Kong L, Wu X, Xu Q: Fraxinellone alleviates kidney fibrosis by inhibiting CUG-binding protein 1-mediated fibroblast activation. Toxicol Appl Pharmacol. 2021 Jun 1;420:115530. doi: 10.1016/j.taap.2021.115530. Epub 2021 Apr 13. [PubMed:33845055 ]
|
|---|